RegCell, Inc.
PrivateLast Round
Series A
Sep 15, 2026
Total Funding Raised
$89.8M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
RegCell, Inc. is a biotechnology company that develops first-in-class regulatory T-cell (Treg) therapies for autoimmune diseases and transplantation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RegCell, Inc. Comparables
Compare RegCell, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sonoma Biotherapeutics | 87% | |
| GentiBio | 85% | |
| Mozart Therapeutics | 84% |
RegCell, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 15, 2026 | ||||
| Seed | Mar 18, 2025 | ||||
| Grant | Mar 18, 2025 |
Key People
Founding team and executive leadership
RegCell, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Seed, Grant |
| Medical Incubator Japan | Series A |
| UTEC (The University of Tokyo Edge Capital Partners) | Series A, Seed |
| Global Brain Corporation | Series A |
| Celadon Partners | Seed |
| LG Technology Ventures | Series A |
| Mitsubishi UFJ Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2026
$44M round led by Playground Global.
- Oct 9, 2025
Scientific Founder awarded Nobel Prize in Physiology or Medicine.
Recent news
Latest coverage and updates
- receives_financingSep 21, 2026
RegCell, Inc. received financing of $22M in non-dilutive funding on Sep 15th '26.
- is_developingSep 21, 2026
RegCell, Inc. is developing first generation of epigenetic reprogramming platform on Jul 1st '24.
- hiresSep 21, 2026
RegCell, Inc. hires Jory Bell as Board of Directors.
RegCell, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RegCell, Inc.'s valuation, stock price, and market status.
Is RegCell, Inc. a public or private company?
RegCell, Inc. is a private company.
What is the current stock price of RegCell, Inc.?
RegCell, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is RegCell, Inc. worth (valuation)?
Valuation information for RegCell, Inc. is not publicly available.
Can I buy RegCell, Inc. stock?
RegCell, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RegCell, Inc.'s last funding round?
RegCell, Inc.'s most recent funding round was Seed on March 18, 2025.
Who are the main investors in RegCell, Inc.?
Key investors in RegCell, Inc. include UTEC (The University of Tokyo Edge Capital Partners), Fast Track Initiative.
Will RegCell, Inc. IPO soon?
No public IPO plans have been announced for RegCell, Inc..
How can I track RegCell, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RegCell, Inc.'s secondary market activity and sign up for updates.